Newton, MA, United States of America

J Thomas Lamont

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 49(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Thomas Lamont: Innovator in Pharmaceutical Compositions

Introduction

J Thomas Lamont is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address critical health issues.

Latest Patents

Lamont holds a patent for "Pharmaceutical compositions containing chondroitinase and uses therefor." This innovative patent highlights the enzyme chondroitinase's potential in preventing gastrointestinal mucus accumulation in patients suffering from cystic fibrosis. His research indicates that gastrointestinal mucus from these patients contains large amounts of chondroitin sulfate polymer, making this enzyme a valuable tool in treating conditions characterized by excess mucus secretion.

Career Highlights

Throughout his career, Lamont has focused on advancing pharmaceutical solutions that improve patient outcomes. His work has been instrumental in understanding the biochemical processes involved in mucus secretion and its implications for various diseases.

Collaborations

Lamont has collaborated with esteemed colleagues, including K Ramakrishnan Bhaskar and Allan M Green. These partnerships have fostered a collaborative environment that enhances the research and development of innovative pharmaceutical solutions.

Conclusion

J Thomas Lamont's contributions to pharmaceutical compositions demonstrate his commitment to addressing significant health challenges. His innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…